Clinical Trials in Italy / NCT06313333
Recruiting
Observational
National Register of Moderate and Severe Adult Atopic Dermatitis
NCT06313333 · tracked via the Priya Life Science Italy tracker
Condition(s) studied
Atopic Dermatitis
Study summary
Collect clinical history and treatment data of AD in adulthood;
Eligibility
Inclusion Criteria:
1. Age 18 years
2. Signature of informed consent
3. Diagnosis of moderate and/or severe DA by a dermatologist specialist defined on the basis of following criteria (10):
* EASI 16
* EASI \<16 but with at least one of the following conditions:
1. location in at least one of the following "critical" locations: face, hands, genitals
2. QID \> 10
3. VAS itching \> 7
4. VAS sleep \> 7
Exclusion Criteria:
1. Patient unable to provide informed consent prior to any collection procedures data on the study;
2. unable to complete the procedures required for the study;
3. a patient already participating in another follow-up register of the same disease.
Primary outcome measure(s)
- Epidemiological data — from baseline through study completion, an average of 3 year
Reassessment of the epidemiology of AD - Identification of factors for specific treatment — from baseline through study completion, an average of 3 year
Assessment of treatment profiles and identification of factors that determine the decision about the specific treatment of moderate and severe AD - clinical and therapeutic data — from baseline through study completion, an average of 3 year
Assessment of any comorbidities; - characterization of diagnostic criteria — from baseline through study completion, an average of 3 year
Outlining possible diagnostic criteria specific to AD in adults; - Assessment of possible conditioning factors — from baseline through study completion, an average of 3 year
Evaluation of the natural history of AD and identification of possible conditioning factors;
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| ASST Spedali Civili di Brescia | Brescia | Brescia | Recruiting |
More Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse trials in Italy
Other trials for the same condition
A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis
Active, not recruiting
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06313333 on ClinicalTrials.gov ↗ ← All trials in Italy